Systematic review of reversible cerebral vasoconstriction syndrome (Q34489830)

2 August 2017

Systematic review of reversible cerebral vasoconstriction syndrome (English)

1 reference

2 August 2017

1 reference

1 reference

Ahsan Sattar

1

1 reference

PubMed ID

20936928

2 August 2017

Georgios Manousakis

series ordinal

2

1 reference

PubMed ID

20936928

2 August 2017

Matthew B Jensen

series ordinal

3

1 reference

2 August 2017

1 October 2010

1 reference

Expert Review of Cardiovascular Therapy

2 August 2017

1 reference

2 August 2017

8

1 reference

2 August 2017

10

1 reference

2 August 2017

1417-1421

1 reference

Reversible cerebral vasoconstriction syndrome: case report

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Reversible cerebral vasoconstriction syndrome: a thunderclap headache-associated condition

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Thunderclap headache attributed to reversible cerebral vasoconstriction: view and review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Narrative review: reversible cerebral vasoconstriction syndromes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Postpartum angiopathy with reversible posterior leukoencephalopathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Reversible cerebral segmental vasoconstriction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Transcranial color doppler study for reversible cerebral vasoconstriction syndromes.

6 July 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Reversible cerebral vasoconstriction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Reversible cerebral vasoconstriction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Cerebral vasoconstriction and stroke after use of serotonergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Reversible cerebral vasoconstriction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.124

Three paediatric patients with reversible cerebral vasoconstriction syndromes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3020907

Case reports: postpartum cerebral angiopathy in a patient with chronic migraine with aura

9 December 2018

1 reference

12 December 2020

Recurrent thunderclap headache associated with reversible intracerebral vasospasm causing stroke

1 reference

12 December 2020

[Effect of the Ca antagonist nimodipine on global and regional cerebrovascular circulation]

1 reference

12 December 2020

Cerebral vasoconstriction syndromes

1 reference

12 December 2020

CT angiography and diffusion-perfusion MR imaging in a patient with ipsilateral reversible cerebral vasoconstriction after carotid endarterectomy

1 reference

12 December 2020

Migraine angiitis precipitated by sex headache and leading to watershed infarction

1 reference

12 December 2020

Postpartum angiopathy and other cerebral vasoconstriction syndromes

1 reference

12 December 2020

Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy

1 reference

12 December 2020

Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome

1 reference

12 December 2020

Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage

1 reference

12 December 2020

Identifiers

DOI

10.1586/ERC.10.124

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

20936928